LEE'S PHARMACEUTICAL HOLDINGS LIMITED Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.
Lee's Pharmaceutical Holdings Limited ҽˤɽᖹᅀછٰϞࠢʮ̡*
(incorporated in the Cayman Islands with limited liability)
(Stock Code: 950)
EXTRAORDINARY GENERAL MEETING HELD ON 15 MARCH 2021 - POLL RESULTS
The poll results in respect of the resolutions proposed at the Extraordinary General Meeting (the "EGM") of Lee's Pharmaceutical Holdings Limited (the "Company") held on 15 March 2021 are as follows:
RESOLUTIONS | Number of votes (approximate %) | Total number of votes cast | ||
For | Against | |||
1. | To approve the spin-off of Zhaoke Ophthalmology Limited ("Zhaoke Ophthalmology"), currently an associated company of the Company, and a separate listing of the new shares of Zhaoke Ophthalmology on The Stock Exchange of Hong Kong Limited (the "Proposed Spin-off"). | 329,936,423 (100.0%) | 5 (0.0%) | 329,936,428 |
The resolution was duly passed as an ordinary resolution. | ||||
2. | To authorise the directors of the Company, for and on behalf of the Company, to take all steps and do all acts and things as they consider to be necessary, appropriate or expedient in connection with and to implement or give effect to the Proposed Spin-off and to execute all such other documents, instruments and agreements (including the affixation of the Company's common seal) deemed by them to be incidental to, ancillary to or in connection with the Proposed Spin-off. | 329,636,423 (100.0%) | 5 (0.0%) | 329,636,428 |
The resolution was duly passed as an ordinary resolution. |
*For identification purpose only
As at the date of the EGM, the total number of ordinary shares of the Company (the "Shares") in issue was 588,125,343 Shares, being the total number of Shares entitling the holders thereof (the "Shareholders") to attend and vote for or against all the resolutions proposed at the EGM. There were no Shares entitling the Shareholders to attend and abstain from voting in favour pursuant to Rule 13.40 of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited (the "Listing Rules"). There were no Shareholders that are required under the Listing Rules to abstain from voting.
HLM CPA Limited, the Company's auditor, acted as scrutineers for the poll at the EGM.
By order of the Board
Lee's Pharmaceutical Holdings Limited
Lee Siu Fong
Chairman
Hong Kong, 15 March 2021
As at the date of this announcement, Ms. Lee Siu Fong (Chairman), Ms. Leelalertsuphakun Wanee and Dr. Li Xiaoyi are executive directors of the Company, Mr. Simon Miles Ball is a non-executive director of the Company, Dr. Chan Yau Ching, Bob, Mr. Lam Yat Cheong and Dr. Tsim Wah Keung, Karl are independent non-executive directors of the Company.
Attachments
- Original document
- Permalink
Disclaimer
Lee's Pharmaceutical Holdings Limited published this content on 15 March 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 15 March 2021 10:54:01 UTC.
